Browse treatments

…and mortality. The management of ICI myocarditis often involves immunosuppressive therapies, as guided by both serum and imaging biomarkers. Elevated level…

…cardiovascular events (MAACE) in a DCM cohort receiving optimal GDMT.Methods We analysed a cohort of 187 patients enrolled in the pr…

…rs.Method Between April 2019 and September 2020, robot-assisted MIDCAB (LIMA-LAD) was performed in 52 patients by a single surgeon. We…

…ts experienced 2.36-fold increased mortality risk compared with SAG-CABG (hazard ratio 2.36, 95% CI 1.96–2.83, P<0.001). This associatio…

…ecurred in 24%; repeat ablation was required in 12%.Conclusions CNA demonstrates sustained efficacy and safety for refractory VVS w…

…Six studies, including 17,068 patients, met inclusion criteria. Beta-blocker therapy was not associated with a significant reduction in all-cause mo…

…ntially remodelled in diarrhoea and non-diarrhoea patients with irinotecan therapy, and the susceptibility was transmissible to recipient mice via…

…ty to evaluate whether community-wide mass drug administration (cMDA) could reduce these disparities by reaching children outside th…

…n for CP/CPPS remains limited. Recent studies demonstrated that vagus nerve stimulation may improve chronic pelvic and abdominal pain. Accordingly, tra…

…% preoperatively to 21.9% postoperatively ( p<0.01).Conclusions ERAI appears to be a feasible and safe super-minimally invasive proc…

…vir/rilpivirine (CAB/RPV-LA), compared with PWH continuing oral ART, extending follow-up to 96 weeks.Methods T-cell immune activati…

…s the fourth 90% target in HIV care, yet remains largely unmet. Antiretroviral therapy (ART) is the only pharmacological intervention consistently sho…